Johnson and Johnson

J&J says its single dose protects against breakthrough COVID-19 for up to 6 months

Johnson & Johnson said that a real-world study showed its single shot COVID-19 vaccine protects against breakthrough infections and hospitalizations for up to six months. The study, sponsored by the…

Read More Here

EU says decision on J&J COVID-19 vaccine booster dose ‘within weeks’

Nov 22 (Reuters) - The European Union's drug regulator said on Monday it was evaluating data on booster doses of the COVID-19 vaccine by Johnson & Johnson and a decision…

Read More Here

J&J COVID-19 shot gets better boost from Moderna or Pfizer in NIH study

People who got Johnson & Johnson Inc’s COVID-19 vaccine as a first shot had a stronger immune response when boosted with vaccines from Pfizer Inc /BioNTech SE or Moderna Inc,…

Read More Here

UPDATED: Johnson & Johnson recalls sunscreens after carcinogen found in some sprays

Johnson & Johnson is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a cancer-causing chemical in some samples. The New Jersey-based company said on Wednesday that…

Read More Here

U.S. issues new warning on J&J vaccine

The U.S. Food and Drug Administration on Monday added a warning to the fact sheet for Johnson & Johnson's COVID-19 vaccine saying that data suggests there is an increased risk…

Read More Here

South African health inspectors will not release unsuitable J&J vaccines

South African health inspectors on Sunday said they will not release Johnson & Johnson COVID-19 vaccines that may have been contaminated during production at a U.S. plant. The South African…

Read More Here

EU says reduction in J&J vaccine deliveries only temporary

The European Commission said on Monday that the reduction in deliveries of COVID-19 vaccines from Johnson & Johnson to EU member states was only temporary, and the company was still…

Read More Here

Update – Britain approves J&J COVID-19 vaccine for use

Britain's medicine regulator has approved Johnson & Johnson's COVID-19 vaccine for use, the health ministry said in a statement on Friday, making it the fourth COVID-19 shot available for use…

Read More Here

Who and how is making use of AstraZeneca, J&J COVID vaccines

April 24 (Reuters) - Following is an outline of countries that have restricted or suspended use of COVID-19 vaccines from AstraZeneca and Johnson & Johnson, after Europe confirmed possible links…

Read More Here

UPDATED: European countries to resume J&J COVID vaccine deliveries

European countries prepared on Wednesday to resume deliveries of Johnson & Johnson's COVID-19 vaccine and speed up the rollout after Europe's drug regulator backed the shot. Germany's health ministry said…

Read More Here

UPDATE – EU regulator backs J&J shot, finds possible link to clots

April 20 (Reuters) - Europe's drug regulator has found a possible link between Johnson & Johnson's COVID-19 vaccine and rare blood clotting issues in adults who received doses in the…

Read More Here

J&J COVID-19 vaccine reviewed for links to additional reports of severe side effects -CDC

April 19 (Reuters) - The United States is reviewing reports of a handful of potential cases of severe side effects among people who received Johnson & Johnson's COVID-19 vaccine in…

Read More Here

J&J scientists refute idea that COVID-19 vaccine’s design linked to clots

CHICAGO, April 16 (Reuters) - Scientists at Johnson & Johnson on Friday refuted an assertion in a major medical journal that the design of their COVID-19 vaccine, which is similar AstraZeneca's, may explain why both have been linked to…

Read More Here

No Causal Link Found So Far Between J&J’s Covid-19 Vaccine & Blood-Clot Cases, Company Researchers Say – WSJ

Johnson & Johnson said Friday there wasn’t enough evidence to establish that the company’s Covid-19 vaccine causes the rare blood-clotting condition that prompted U.S. health officials this week to recommend a…

Read More Here

Pfizer and Moderna decline request by J&J to study the risks of blood clots – WSJ

(Reuters) - Johnson & Johnson had reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots, but Pfizer Inc and Moderna…

Read More Here

Italy suspends distribution of J&J shots after use paused in U.S

ROME (Reuters) - Italy said on Wednesday it had suspended the use of some 184,000 shots of the Johnson & Johnson COVID-19 vaccine, after the brand delayed its introduction in…

Read More Here

EU medicine regulator EMA to issue recommendation on J&J vaccine next week

April 14 (Reuters) - Europe's drug regulator said on Wednesday it expects to issue a recommendation on Johnson & Johnson's COVID-19 vaccine next week and that it continues to believe…

Read More Here

J&J says delaying rollout of COVID-19 vaccine in Europe

(Reuters) - Johnson & Johnson said on Tuesday it would delay the rollout of its COVID-19 vaccine in Europe and was reviewing cases of extremely rare blood clots in people…

Read More Here

U.S. calls for pause to J&J COVID-19 vaccine over rare blood clots

U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson's COVID-19 vaccine after six recipients developed a rare disorder involving blood clots, in a fresh setback…

Read More Here

Greece to receive first 33,600 doses of J&J COVID-19 vaccine this week

ATHENS, April 12 (Reuters) - Greece will get a first tranche of the single-dose Johnson & Johnson vaccine against COVID-19 on Wednesday and will start inoculating people with it next…

Read More Here

UK millennials to be offered single-shot Johnson & Johnson COVID vaccine to ‘jab and go’- The Telegraph

A new single shot Covid-19 vaccine could be available by July and will be mainly used to target young millennials who might not want to wait for three months for…

Read More Here

EMA gives green light to J&J’s single-shot COVID-19 vaccine

March 11 (Reuters) - The European Union's drugs regulator on Thursday recommended conditionally approving Johnson & Johnson's single dose COVID-19 vaccine, as the bloc seeks to speed up a stuttering…

Read More Here

U.S. authorises J&J’s COVID-19 vaccine, making it third available

Feb 27 (Reuters) - The U.S. government on Saturday authorized Johnson & Johnson's single-dose COVID-19 vaccine, enabling millions more Americans to be vaccinated in the coming weeks and setting the…

Read More Here

Johnson & Johnson has only a few million COVID-19 vaccine doses in stock as likely launch nears

Feb 17 (Reuters) - Johnson & Johnson has only a few million doses of its experimental COVID-19 vaccine in its inventory even as likely U.S. regulatory authorization is only a…

Read More Here

Johnson & Johnson COVID-19 vaccine could be available in Europe in April – source

BRUSSELS (Reuters) - Johnson & Johnson could deliver the first doses of its COVID-19 vaccine to Europe in April, an EU official told Reuters on Wednesday after a top lawmaker…

Read More Here

Johnson & Johnson pause Covid-19 vaccine clinical trials due to unexplained illness in study participant

Johnson and Johnson said on Monday it had temporarily paused its COVID-19 vaccine candidate clinical trials due to an unexplained illness in a study participant, delaying one of the highest…

Read More Here

Johnson & Johnson recalls baby powder in US after asbestos discovery

Health care giant Johnson & Johnson has recalled 33,000 bottles of baby powder in the US, after health regulators found trace amounts of asbestos in a bottle purchased online. Government…

Read More Here